MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-40

  1. 3,053 Posts.
    lightbulb Created with Sketch. 2
    MSB haven't done a clinical trial for temcell. Osiris did though, and it failed to meet primary endpoint.

    Please stick to the facts rather than what you wish was true!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.